DNA context and promoter activity affect gene expression in lentiviral vectors

Similar documents
Certificate of Analysis

Certificate of Analysis

Jumpstart your research with ViraPower Lentiviral Expression Systems

Pre-made Lentiviral Particles for Fluorescent Proteins

Your Gene ATG GGT. pd1118 EF1a-ORF, Lenti-ElecD 7803 bp

Choosing Between Lentivirus and Adeno-associated Virus For DNA Delivery

QuickTiter Lentivirus Titer Kit (Lentivirus-Associated HIV p24)

QuickTiter Lentivirus Quantitation Kit (HIV p24 ELISA)

Supplementary Information. Novel lentiviral vectors with mutated reverse transcriptase for mrna delivery of TALE nucleases

VIRAL TITER COUNTS. The best methods of measuring infectious lentiviral titer

A method to mathematically determine transduction efficiency of lentivirus in HeLa cells Research Article

Pre-made Reporter Lentivirus for JAK-STAT Signaling Pathway

~Lentivirus production~

Downloaded by Guangxi University for Nationalities from online.liebertpub.com at 02/24/18. For personal use only. ABSTRACT

Certification Assays for HIV-1-Based Vectors: Frequent Passage of Gag Sequences without Evidence of Replication-Competent Viruses

Constitutive Reporter Lentiviral Vectors Expressing Fluorescent Proteins

Supplemental Materials and Methods Plasmids and viruses Quantitative Reverse Transcription PCR Generation of molecular standard for quantitative PCR

Pre-made Reporter Lentivirus for MAPK/ERK Signal Pathway

VIROLOGY. Engineering Viral Genomes: Retrovirus Vectors

Supplementary Information. Supplementary Figure 1

CRISPRaTest Functional dcas9-activator Assay Kit v1 Last update: 2018/07/04 Cellecta, Inc.

Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element Enhances Expression of Transgenes Delivered by Retroviral Vectors

Pre-made Lentiviral Particles for intracelular labeling: (LocLight TM Living cell imaging lentivirus for sub-cellular localization)

A Stable System for the High-Titer Production of Multiply Attenuated Lentiviral Vectors

A phase I pilot study of safety and feasibility of stem cell therapy for AIDS lymphoma using stem cells treated with a lentivirus vector encoding

Supplemental Information

QuickTiter Lentivirus Titer Kit (Lentivirus-Associated HIV p24)

Rabies virus-like particles expressed in HEK293 cells

Pre-made Reporter Lentivirus for NF-κB Signal Pathway

Ready-to-use Lentiviral Particles for intracelular labeling

CENTRO NACIONAL DE PESQUISA EM ENERGIA E MATERIAIS LABORATÓRIO NACIONAL DE BIOCIÊNCIAS LABORATÓRIO VETORES VIRAS- LVV 21º PROGRAMA BOLSAS DE VERÃO

Development of a Sensitive Assay for Detection of Replication-Competent Recombinant Lentivirus in Large-Scale HIV-Based Vector Preparations

Purified Rabbit Anti Human AATF Polyclonal antibody Lenti-Easy-His Gene Expression System Cat No: LV100 Catalog No: Y054422

1ME A17R11 WI238 DMS2114 JC L2929 P815 PT67

Lenti-Bicistronic & Tricistronic Expression Systems

Lenti-miRNA Expression Systems

Research Lentiviral vector design using alternative RNA export elements Taekeun Oh 3, Ali Bajwa 4, Guangfu Jia 1 and Frank Park* 1,2

Lentiviral vectors titration using real-time PCR

LENTI-Smart. For the generation of lentiviral particles USER MANUAL. FOR RESEARCH PURPOSES ONLY

Plasmid DNA and adenoviral vectors have been used in

Trans-Lentiviral TM Packaging System

Review and Public RAC Discussion of Protocol #

Gene transfer into stimulated and unstimulated T lymphocytes by HIV-1-derived lentiviral vectors

Feb 11, Gene Therapy. Sam K.P. Kung Immunology Rm 417 Apotex Center

Multi-plasmid approach

LENTI-Smart OSKM USER MANUAL FOR RESEARCH PURPOSES ONLY.

PROTOCOL: OPTIMIZATION OF LENTIVIRAL TRANSDUCTION USING SPINFECTION

Kathy Heivilin. October 30, Dr. Brent Ryckman DBS University of Montana Missoula, MT Dear Dr. Ryckman,

MyBioSource.com. QuickTiter Lentivirus Titer Kit (Lentivirus-Associated HIV p24) Product Manual. Catalog Number. MBS x 96 assays

Hepatitis B Antiviral Drug Development Multi-Marker Screening Assay

BMC Biotechnology. Open Access. Abstract

ARTICLE IN PRESS. The Effect of Age on Hepatic Gene Transfer with Self-Inactivating Lentiviral Vectors in Vivo

The Choice of a Suitable Lentivirus Vector

Product Information: CellPlayer NeuroLight Red Lentivirus - Synapsin Promoter Catalog Number: 4584

HEK293FT cells were transiently transfected with reporters, N3-ICD construct and

Recombinant Protein Expression Retroviral system

Development of Multigene and Regulated Lentivirus Vectors

Graveley Lab shrna knockdown followed by RNA-seq Biosample Preparation and Characterization Document

Viral Vectors In The Research Laboratory: Just How Safe Are They? Dawn P. Wooley, Ph.D., SM(NRM), RBP, CBSP

RESEARCH ARTICLE Gene transduction efficiency in cells of different species by HIV and EIAV vectors. Introduction. Results

Hybrid HIV/MSCV LTR Enhances Transgene Expression of Lentiviral Vectors in Human CD34 + Hematopoietic Cells

Gene Transfer Vector Derived from Jembrana Disease Virus: A Review

Lenti-X Provirus Quantitation Kit User Manual

JOURNAL OF VIROLOGY, Dec. 2000, p Vol. 74, No. 24. Copyright 2000, American Society for Microbiology. All Rights Reserved.

Regulation of cell signaling cascades by influenza A virus

Retro-X qrt-pcr Titration Kit User Manual

Supporting Information

Table of Contents. Product and Service Item of Genemedi Lentivirus...3 Product Character of Genemedi Lentivirus...3

Replication-competent Lentivirus Analysis of Clinical Grade Vector Products

Lentivector Expression Systems:

SUPPLEMENTARY INFORMATION. Supplementary Figures S1-S9. Supplementary Methods

Primate and Feline Lentivirus Vector RNA Packaging and Propagation by Heterologous Lentivirus Virions

SHORT COMMUNICATION SIV MAC Vpx improves the transduction of dendritic cells with nonintegrative HIV-1-derived vectors

Supplementary Material

Supplementary Figure 1. Establishment of prostacyclin-secreting hmscs. (a) PCR showed the integration of the COX-1-10aa-PGIS transgene into the

LentiBoost Lentiviral Transduction Enhancer

mrna mrna mrna mrna GCC(A/G)CC

RESEARCH ARTICLE Advanced generation lentiviruses as efficient vectors for cardiomyocyte gene transduction in vitro and in vivo

A Lentiviral cdna Library Employing Lambda Recombination Used To Clone an Inhibitor of Human Immunodeficiency Virus Type 1-Induced Cell Death

A VLP vaccine for epidemic Chikungunya virus protects non-human primates against infection

TEPZZ 48Z678B_T EP B1 (19) STABILE HERSTELLUNG VON LENTIVIRALEN VEKTOREN PRODUCTION STABLE DE VECTEURS LENTIVIRAUX (11) EP B1

Screening for Complex Phenotypes

Minimum Requirements for Efficient Transduction of Dividing and Nondividing Cells by Feline Immunodeficiency Virus Vectors

Antiviral restriction factor transgenesis in the domestic cat

Carolyn Lutzko, 1,2 * Dinithi Senadheera, 1 Dianne Skelton, 1 Denise Petersen, 1 and Donald B. Kohn 1,2

Functional characterisation of hepatitis B viral X protein/microrna-21 interaction in HBVassociated hepatocellular carcinoma

Cignal Lenti Reporters

PBMC from each patient were suspended in AIM V medium (Invitrogen) with 5% human

Graveley Lab shrna knockdown followed by RNA-seq Biosample Preparation and Characterization Document

Transduction of dendritic cells by antigen-encoding lentiviral vectors permits antigen processing and MHC class I dependent presentation

Transcriptional Targeting of Lentiviral Vectors by Long Terminal Repeat Enhancer Replacement

Luciferase (Firefly and Renilla) Expression Stable Cell Lines

TITLE: Anti-Angiogenic Gene Therapy of Prostate Cancer with Lentiviral Vectors

Choosing Optimal Viral Vector for T-cell Transduction. Viral vectors for blood cells

Soft Agar Assay. For each cell pool, 100,000 cells were resuspended in 0.35% (w/v)

OCCUPATIONAL HEALTH CONSIDERATIONS FOR WORK WITH VIRAL VECTORS

QuickTiter Lentivirus Titer Kit (Lentivirus-Associated HIV p24)

ARTICLE doi: /mthe , available online at on IDEAL A B C FIG. 1. GFP expression of HIV-1 and FIV transduced h

Transcription:

ACTA BIOMED 2008; 79: 192-196 Mattioli 1885 O R I G I N A L A R T I C L E DNA context and promoter activity affect gene expression in lentiviral vectors Gensheng Mao 1, Francesco Marotta 2, Jia Yu 3, Liang Zhou 3, Yan Yu 3, Lina Wang 3, Dehua Chui 3 1 Department of Neurosurgery, Chinese People s Armed Police Forces General Hospital, Beijing 100039, Chin; 2 Aging Intervention & Research Department, GAIA Foundation, Milano, Italy; 3 Neuroscience Research Institute and Department of Neurobiology, Key Lab. for Neuroscience, Peking University, Beijing, China Abstract. Several varieties of lentiviral delivery systems have been used to generate stable cell lines and transgenic animals. Some enhancing elements have been identified to promote stable transgene expression. In this study, we describe that the promoter activity is affected by the lentiviral genomic context. We have examined the promoter activities using green fluorescence protein (GFP) as a reporter in different cell lines to demonstrate that the cytomegalovirus (CMV) promoter may not always be the best choice to overexpress transgenes in all cell types. Our data showed that the polypeptide chain elongation factor 1 alpha (EF1α) promoter is relatively active in all three model cell lines (293T, HOS, and Hela) while the CMV promoter is less effective in Hela cells. (www.actabiomedica.it) Key words: DNA context, promoter activity, elongation factor 1 alpha Introduction Lentiviral vectors have been considered as an effective gene delivery system due to the following features: 1) ability to infect non-dividing cells, 2) high efficiency of gene delivery and broad range of infectivity while using the vescicular stomatitis virus G (VSVG) envelope protein, and 3) integration into host genome for long-term gene expression (1-6). At least three generations of lentiviral vectors have been evolved in the last decade (1, 7, 8). Different regulatory elements and promoters have been introduced into the lentiviral vectors to increase the overexpression efficacy. In this study, we have focused on the DNA context of the lentiviral vectors and the effect of cell types on promoter activities. Materials and Methods Construction of lentiviral vectors The lentiviral vector plenti6.2-gw/egfp was purchased from Invitrogen (Carlsbad, CA, USA). The construction of lentiviral vector plv-cmv-gfp has been described in (2, 3), plasmids plv-ef1α- GFP and plv-pgk-gfp were derived from plv- CMV-GFP by replacing the CMV promoter. The DNA segment containing polypeptide chain elongation factor 1 alpha (EF1α) promoter was amplified from human liver genomic DNA using primers, EF1- F (ggccatcgatgcctccccgtcaccaccccccccaa) and EF1-R (ggcctctagaggggtagttttcacgacacctgaaatgg) by PCR. The DNA segment containing phosphoglycerate kinase (PGK) promoter was amplified from 3T3 genomic DNA using primers PGK-F (ggccatcgataattctaccgggtaggggaggcg) and PGK-R (ggcctctctagacaggtcgaaaggcccggagatgagg). Both promoters were cloned into ClaI and XbaI sites of plv-cmv-egfp to replace the CMV promoter. Lentiviral production The transfection reagent lipofectamin 2000 and the lentiviral packaging mix were purchased from In-

DNA context and promoter activity affect gene expression in lentiviral vectors 193 vitrogen (Carlsbad, CA, USA). The cell culture medium and supplements were purchased from Hyclone (Logan, UT, USA). The transfection procedure was followed the manufacturer s protocol and the supernatants were collected at 48 hours post transfection. The lentiviral stocks were then treated with DNaseI (10 units/ml) at 37ºC for 15 min, filtered through 0.45 mm filters, and stored at -80 C. The human cell lines 293T, HT1080, Hela, and HOS used in transduction experiments were purchased from ATCC (Manassas, VA, USA). Determination of virus titer The titers of different lentiviral stocks generated in this study were determined by FACS (functional GFP titer) and real-time PCR (DNA titer). To determine functional GFP titers, 100 µl 5-fold serial dilutions of lentiviruses were added to 5 x 10 4 293T cells per well in 6-well plates. The transduced cells were trypsinized, collected and resuspended for flow cytometry to determine the percentage of green fluorescent cells at 48 hours post transduction. To determine DNA titers, total DNA was isolated using Qiagen DNeasy kit at 24 hours after transduction. Quantitative PCR was carried out by using ABI Prism 7700 with Invitrogen LUX primers (LV-FL: cgccgtggaaaatctctagcagtggcg, and LV-RU: gctcctctggtttccctttcg). The amplification condition was described in (9). Figure 1. Schematic structure of the lentiviral vectors. The abbreviations are described as follow: RRE, Rev-response element; SD, splice donor; SA, splice acceptor; cppt, central polypurine tract; WPRE, Woodchuck hepatitis posttranscriptional regulatory element; Bsd, blasticidin; attb1 and attb2, Gateway site-specific recombination sequences from plv-cmv-gfp, plv-ef1α-gfp, and plv- PGK-GFP vectors are varied (Fig. 2B-D). The data showed that 293T cells harboring CMV-GFP, EF1α- GFP, and PGK-GFP vectors displayed high, medium, and low intensity of green fluorescence, respectively (Fig. 2B-D). It suggests that the CMV, EF1α, and PGK promoters are listed in the order of promoter activity from the highest to the lowest in the 293T cells. By comparing the intensity of green fluorescence expressed from CMV promoters on plenti6.2-egfp and plv-cmv-gfp vectors, the level of GFP expressed from plv-cmv-gfp is much higher than GFP expressed from plenti6.2-egfp (Fig. 2A and D). The lentiviral stocks were further analyzed by Results DNA context of lentiviral vectors affects gene expression All of the lentiviral vectors used in this study contain GFP gene as a reporter (Fig. 1). The major differences among plenti6.2-egfp and plv-gfp vectors are no central polypurine tract (cppt) sequence and Woodchuck hepatitis posttranscriptional regulatory element (WPRE) in the plenti6.2-egfp vector. To determine whether the level of EGFP expression is only dependent on the strength of promoters, 293T cells were transfected with plenti6.2-egfp and three plv-gfp vectors. The GFP expression Figure 2. Transfecting 293T cells with lentiviral vectors. The 293T cells were transfected with (A) plenti6.2-gw/egfp, (B) plv-pgk-gfp, (C) plv-ef1α-gfp, and (D) plv- CMV-GFP

194 G. Mao, F. Marotta, J. Yu, et al. Table 1. Titering plv-cmv-gfp and plenti6.2-gw/egfp by FACS and realtime PCR Lentivirus DNA copy no./ml GFP positive cells/ml Mean Fluorescence Signal LV-CMV-GFP 2.3 ± 0.1 x 10 8 (100%) 6.3 ± 0.2 x 10 6 (100%) 1395 ± 52 (100%) Lenti6.2-GW/EGFP 1.3 ± 0.0 x 10 8 (57%) 5.6 ± 0.4 x 10 5 (8.9%) 64 ± 12 (4.6%) quantitative PCR to determine the DNA titer and the same DNA titers of plenti6.2-gw/egfp and plv- CMV-GFP lentiviral stocks were used to transduce 293T and HT1080 cells (Table 1). The plv-cmv- GFP vector in 293T and HT1080 cells expressed higher levels of GFP than the GFP expressed from plenti6.2-gw/egfp vector while both cell lines were transduced with same DNA titers of viruses (Fig. 3B vs. 3A, 3D vs. 3C). The results confirm the lentiviral vector sequences affect the level of transgene expression. The promoter activities are altered by different types of cells In the experiments of 293T cells transfected with plv-gfp vectors, the CMV promoter showed the highest activity in GFP expression in 293T cells. However, when the 293T cells were transduced with same copy number of plv-cmv-gfp, plv-ef1α- GFP, and plv-pgk-gfp viruses and the level of GFP expression was determined by flow cytometry; the data showed that the overall GFP expression from CMV promoter is 4.2 and 6.3 folds higher than GFP Figure 3. Examination of lentiviral GFP expression in 293T and HT1080 cells. The 293T and HT1080 cells was transduced with the same titer of plv-cmv-gfp and plenti6.2- GW/EGFP lentiviruses for 48 hours Table 2. FACS analysis of plv-gfp transduction in 293T cells Lentivirus GFP positive Mean Fluorescence cells/ml Signal LV-CMV-GFP 3.0 ± 0.1 x 106 (100%) 476 ± 14 (100%) LV-EF1α-GFP 3.0 ± 0.2 x 106 (100%) 74 ± 0.4 (16%) LV-PGK-GFP 2.8 ± 0.3 x 106 (93%) 104 ± 4.8 (22%) expressing from PGK and EF1α promoters, respectively (Table 2, Fig. 4D-F). To investigate whether the promoter activities are influenced by different types of cells; The HOS and Hela cells were transduced with same DNA titers of viruses. In the HOS cells, the CMV and EF1α showed a similar level of activity (Fig. 4G-I). On the contrary, the EF1α is the most active promoter in the Hela cells (Fig. 4 J-L). Discussion The lentiviral transduction is one of the most effective methods to overexpress transgenes. However, the influence of the lentiviral DNA context on overexpression still has to be considered. In this study, we have shown that the GFP expression from the CMV promoter encoded in two lentiviral vectors, plenti6.2- GW/EGFP and plv-cmv-gfp, reveals 20-fold differences (Table 1 and Fig. 2). The differential expression of GFP reporter may be due to plenti6.2- GW/EGFP vector was lacking some cis-acting elements such as central polypurine tract (cppt) sequence and Woodchuck hepatitis posttranscriptional regulatory element (WPRE). It has been reported that the cppt sequence and WPRE in the lentiviral vectors contribute to a higher transgene expression and virus titer (8, 10). Cloning cppt sequence and WPRE into plenti6.2-gw/egfp has increased GFP expression up to 10-fold (data not shown). In addition to transfecting 293T cells, transducing 293T and HT1080 cells with plenti6.2-gw/egfp and

DNA context and promoter activity affect gene expression in lentiviral vectors 195 Figure 4. Comparing promoter activities in different cell lines. (A-C). The 293T cells were transfected with plv-gfp vectors. (D-L). The 293T, HOS, and Hela cells were transduced with same titer of lentivirus to compare the level of gene expression plv-cmv-gfp showed the consistent results (Fig. 3). The results indicate that the differential expression of GFP between plenti6.2-gw/egfp and plv- CMV-GFP is due to the lentiviral genomic sequences but not the plasmid topology. The multiplicity of infection (MOI) may be underestimated if using functional GFP titer. In table 1 the numbers of GFP-positive cells were 10-fold difference between plv-cmv-gfp and plenti6.2- GW/EGFP transductions while the DNA titers showed that the DNA copy numbers only differed in 1 fold. The data suggest if the context of lentiviral genome affects the production of GFP, then determining the copy number of lentivirus using GFP titer may not be accurate. Moreover, it has been reported that the estimation of lentiviral cdna copy number in the transduced cell lines is more reliable than using the level of GFP expression to titer lentiviruses (11). The CMV promoter may not always be the best choice for transgene overexpression in all cell types. By comparing to other promoters, while CMV promoter gave more than 6-fold of GFP expression than human house keeping gene EF1α promoter in 293T cells, the GFP production by EF1α promoter revealed the highest intensity in Hela cells. Acknowledgements This work was supported by a grant from the National Science Foundation of China (NSFC: 30570553 and 3067414) and 973 Key Basic Research Program (2006CB500705).

196 G. Mao, F. Marotta, J. Yu, et al. References 1. Miyoshi H, Blomer U, Takahashi M, Gage FH, Verma IM. Development of a self-inactivating lentivirus vector. J Virol 1998; 72: 8150-7. 2. Naldini L, Blomer U, Gage FH, Trono D, Verma IM. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA 1996; 93: 11382-8. 3. Naldini L, Blomer U, Gallay P, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996; I272: 263-7. 4. Cherry SR, Biniszkiewicz, D, van Parijs L, Baltimore D, Jaenisch R. Retroviral expression in embryonic stem cells and hematopoietic stem cells. Mol Cell Biol 2000; 20: 7419-26. 5. Ikawa M, Tanaka N, Kao WW, Verma IM. Generation of transgenic mice using lentiviral vectors: a novel preclinical assessment of lentiviral vectors for gene therapy. Mol Ther 2003; 8: 666-73. 6. Pfeifer A, Ikawa M, Dayn Y, Verma IM. Transgenesis by lentiviral vectors: lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos. Proc Natl Acad Sci USA 2002; 99: 2140-5. 7. Dull T, Zufferey R, Kelly M, et al. A third-generation lentivirus vector with a conditional packaging system. J Virol 1998; 72: 8463-71. 8. Zufferey R, Donello JE, Trono D, Hope TJ. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol 1999; 73: 2886-92. 9. Butler SL, Hansen MS, Bushman FD. A quantitative assay for HIV DNA integration in vivo. Nat Med 2001; 7: 631-4. 10. Park F, Kay MA. Modified HIV-1 based lentiviral vectors have an effect on viral transduction efficiency and gene expression in vitro and in vivo. Mol Ther 2001; 4: 164-73. 11. Sastry L, Johnson T, Hobson MJ, Smucker B, Cornetta, K. Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods. Gene Ther 2002; 9: 1155-62. Accepted: July 2nd 2008 Correspondence: Dehua Chui Neuroscience Research Institute, Peking University 38 Xueyin Road P.R. China Beijing 100191 E-mail: dchui@bjmu.edu.cn; www.actabiomedica.it